X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (504) 504
Publication (38) 38
Book Review (6) 6
Magazine Article (6) 6
Trade Publication Article (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (437) 437
uridine monophosphate - analogs & derivatives (343) 343
index medicus (316) 316
uridine monophosphate - therapeutic use (298) 298
antiviral agents - therapeutic use (296) 296
sofosbuvir (243) 243
hepatitis c, chronic - drug therapy (231) 231
male (200) 200
female (177) 177
hepacivirus - genetics (137) 137
hepatitis c (137) 137
ribavirin - therapeutic use (137) 137
middle aged (130) 130
benzimidazoles - therapeutic use (126) 126
fluorenes - therapeutic use (126) 126
ribavirin (113) 113
treatment outcome (113) 113
genotype (108) 108
hepatitis c - drug therapy (107) 107
gastroenterology & hepatology (106) 106
drug therapy, combination (105) 105
hepatitis c virus (103) 103
adult (85) 85
hepacivirus - drug effects (81) 81
aged (79) 79
hepatitis (79) 79
animals (76) 76
pharmacology & pharmacy (73) 73
abridged index medicus (70) 70
antiviral agents - adverse effects (70) 70
interferon (68) 68
uridine monophosphate - adverse effects (65) 65
care and treatment (60) 60
drug therapy (59) 59
medicine, general & internal (58) 58
therapy (57) 57
infection (56) 56
ledipasvir (55) 55
hepatitis c, chronic - virology (54) 54
simeprevir (54) 54
antiviral agents (53) 53
uridine monophosphate - economics (53) 53
sulfonamides - therapeutic use (52) 52
uridine (51) 51
antiviral agents - economics (50) 50
cirrhosis (50) 50
antiviral agents - administration & dosage (49) 49
uridine monophosphate - administration & dosage (49) 49
health aspects (48) 48
virus-infection (46) 46
treatment-naive patients (45) 45
viral nonstructural proteins - antagonists & inhibitors (42) 42
heterocyclic compounds, 3-ring - therapeutic use (41) 41
interferon-alpha - therapeutic use (41) 41
liver (40) 40
united states (40) 40
hcv (39) 39
analysis (38) 38
genotype 1 infection (38) 38
hepatitis c, chronic - complications (38) 38
research (38) 38
sustained virological response (38) 38
patients (37) 37
plus ribavirin (36) 36
infectious diseases (35) 35
infections (34) 34
genotype & phenotype (33) 33
polyethylene glycols - therapeutic use (33) 33
benzimidazoles - adverse effects (32) 32
biological response modifiers (32) 32
fluorenes - adverse effects (32) 32
antiviral agents - pharmacology (31) 31
gastroenterology and hepatology (31) 31
medicine (31) 31
telaprevir (31) 31
benzimidazoles - administration & dosage (30) 30
fluorenes - administration & dosage (30) 30
genetic aspects (30) 30
liver cirrhosis - virology (30) 30
mice (30) 30
sustained virologic response (30) 30
hiv infections - drug therapy (29) 29
ribavirin - adverse effects (29) 29
transplantation (28) 28
imidazoles - therapeutic use (27) 27
immunology (27) 27
liver cirrhosis - drug therapy (27) 27
multidisciplinary sciences (27) 27
recurrence (27) 27
united-states (27) 27
young adult (27) 27
hepacivirus - isolation & purification (26) 26
liver cirrhosis (26) 26
oncology (26) 26
article (25) 25
cancer (25) 25
enzymes (25) 25
metabolism (25) 25
research article (25) 25
rna, viral - blood (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (481) 481
German (15) 15
French (5) 5
Russian (4) 4
Japanese (2) 2
Danish (1) 1
Dutch (1) 1
Hungarian (1) 1
Korean (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 20, pp. 1879 - 1888
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 16, pp. 1483 - 1493
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 8, pp. 705 - 713
Among patients coinfected with HIV-1 and HCV genotype 1 or 4 who were receiving effective antiretroviral therapy, treatment with 12 weeks of ledipasvir and... 
MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | INTERFERON | THERAPY | HEPATITIS-C VIRUS | CIRRHOSIS | ALPHA-2A PLUS RIBAVIRIN | VETERANS | GENOTYPE 1 INFECTION | COHORT | LIVER-DISEASE | HIV-1 | Humans | Middle Aged | Drug Resistance, Viral | Fluorenes - therapeutic use | Hepacivirus - genetics | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Viral Load | Female | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Benzimidazoles - adverse effects | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Fluorenes - pharmacokinetics | Hepacivirus - isolation & purification | Anti-Retroviral Agents - therapeutic use | Antiviral Agents - therapeutic use | Benzimidazoles - pharmacokinetics | Genotype | Hepatitis C, Chronic - drug therapy | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | HIV Infections - complications | HIV Infections - drug therapy | Uridine Monophosphate - pharmacokinetics | Sofosbuvir | Care and treatment | Research | Hepatitis C virus | HIV infection | Emtricitabine | Headache | Antiretroviral drugs | Inhibitor drugs | Diarrhea | Fatigue | Patients | Efavirenz | Studies | Tenofovir | Cirrhosis | Genotype & phenotype | Hepatitis | Human immunodeficiency virus--HIV | Hepatitis C | Drug therapy | Genotypes
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 20, pp. 1878 - 1887
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 20, pp. 1889 - 1898
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 149, Issue 3, pp. 649 - 659
Background & Aims There are no effective and safe treatments for chronic hepatitis C virus (HCV) infection of patients who have advanced liver disease. Methods... 
Gastroenterology and Hepatology | Liver Transplantation | Decompensated Cirrhosis | Hepatitis C Virus Infection | Fibrosing Cholestatic Hepatitis | C INFECTION | TRANSPLANTATION PATIENTS | RECIPIENTS | INTERFERON | THERAPY | ADEFOVIR DIPIVOXIL | CIRRHOSIS | GENOTYPE 1 INFECTION | OUTCOMES | GASTROENTEROLOGY & HEPATOLOGY | United States | Humans | Middle Aged | Fluorenes - therapeutic use | Liver Cirrhosis - mortality | Hepacivirus - genetics | Male | Cholestasis, Intrahepatic - drug therapy | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - mortality | Time Factors | Female | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Benzimidazoles - adverse effects | Drug Therapy, Combination | Cholestasis, Intrahepatic - virology | Benzimidazoles - therapeutic use | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Cirrhosis - drug therapy | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Disease Progression | Cholestasis, Intrahepatic - mortality | Hepacivirus - enzymology | Liver Cirrhosis - virology | Cholestasis, Intrahepatic - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Drug Combinations | Care and treatment | Liver diseases | Hepatitis C virus | Hepatitis C | Health aspects
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 3, pp. 211 - 221
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 1, pp. 34 - 44
In this small, preliminary study of sofosbuvir, a nucleotide inhibitor of HCV polymerase, treatment with sofosbuvir and ribavirin, without peginterferon, was... 
GENOTYPE 1 | PSI-7977 | MEDICINE, GENERAL & INTERNAL | VIRUS-INFECTION | THERAPY | REPLICATION | RESISTANCE | REPLICON RNA-SYNTHESIS | COMBINATION | TREATMENT-NAIVE PATIENTS | PROTEASE | Recombinant Proteins - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Adult | Female | RNA, Viral - metabolism | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - isolation & purification | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Hemoglobins - metabolism | Genotype | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Interferon-alpha - adverse effects | Viral Nonstructural Proteins - antagonists & inhibitors | Sofosbuvir | Drugs | Dose-response relationship (Biochemistry) | Antiviral agents | Usage | Patient outcomes | Dosage and administration | Product/Service Evaluations | Drug therapy, Combination | Hepatitis C | Drug therapy | Ribavirin | Hepatitis | Interferon | Infections | Index Medicus | Abridged Index Medicus
Journal Article